CoCl₂, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics in Colon Cancer

• Laura M. Lopez-Sánchez,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Carla Jimenez,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Araceli Valverde,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Vanessa Hernandez,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Jon Peñarando,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Antonio Martinez,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Chary Lopez-Pedrera,

  Affiliation Research Unit, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain

  ⨯
• Juan R. Muñoz-Castañeda,

  Affiliation Research Unit, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain

  ⨯
• Juan R. De la Haba-Rodríguez,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Enrique Aranda,

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Antonio Rodriguez-Ariza

  * E-mail: antonio.rodriguez.exts@juntadeandalucia.es

  Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain

  ⨯